tetano
Editor, Senior Moderator
Expert Rev Vaccines. 2019 May 22. doi: 10.1080/14760584.2019.1622419. [Epub ahead of print]
[h=1]Challenges in estimating influenza vaccine effectiveness.[/h] Ainslie KEC[SUP]1[/SUP], Haber M[SUP]2[/SUP], Orenstein WA[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza vaccination is regarded as the most effective way to prevent influenza infection. Due to the rapid genetic changes that influenza viruses undergo, seasonal influenza vaccines must be reformulated and re-administered annually necessitating the evaluation of influenza vaccine effectiveness (VE) each year. The estimation of influenza VE presents numerous challenges. Areas Covered: This review aims to identify, discuss, and, where possible, offer suggestions for dealing with the following challenges in estimating influenza VE: different outcomes of interest against which VE is estimated, study designs used to assess VE, sources of bias and confounding, repeat vaccination, waning immunity, population level effects of vaccination, and VE in at-risk populations. Expert Opinion: The estimation of influenza VE has improved with surveillance networks, better understanding of sources of bias and confounding, and the implementation of advanced statistical methods. Future research should focus on better estimates of the indirect effects of vaccination, the biological effects of vaccination, and how the vaccine interacts with the immune system. Specifically, little is known about how influenza vaccination impacts an individual's infectiousness, how the vaccine wanes over time, and the impact of repeated vaccination.
[h=4]KEYWORDS:[/h] bias; case-control; challenges; cohort; confounding; effectiveness; influenza; test-negative; vaccination; waning
PMID: 31116070 DOI: 10.1080/14760584.2019.1622419
[h=1]Challenges in estimating influenza vaccine effectiveness.[/h] Ainslie KEC[SUP]1[/SUP], Haber M[SUP]2[/SUP], Orenstein WA[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza vaccination is regarded as the most effective way to prevent influenza infection. Due to the rapid genetic changes that influenza viruses undergo, seasonal influenza vaccines must be reformulated and re-administered annually necessitating the evaluation of influenza vaccine effectiveness (VE) each year. The estimation of influenza VE presents numerous challenges. Areas Covered: This review aims to identify, discuss, and, where possible, offer suggestions for dealing with the following challenges in estimating influenza VE: different outcomes of interest against which VE is estimated, study designs used to assess VE, sources of bias and confounding, repeat vaccination, waning immunity, population level effects of vaccination, and VE in at-risk populations. Expert Opinion: The estimation of influenza VE has improved with surveillance networks, better understanding of sources of bias and confounding, and the implementation of advanced statistical methods. Future research should focus on better estimates of the indirect effects of vaccination, the biological effects of vaccination, and how the vaccine interacts with the immune system. Specifically, little is known about how influenza vaccination impacts an individual's infectiousness, how the vaccine wanes over time, and the impact of repeated vaccination.
[h=4]KEYWORDS:[/h] bias; case-control; challenges; cohort; confounding; effectiveness; influenza; test-negative; vaccination; waning
PMID: 31116070 DOI: 10.1080/14760584.2019.1622419